Addex Therapeutics Ltd.

ADXN

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001574232

SEC filings (opens in a new tab)

No open-market purchases or sales by Addex Therapeutics Ltd. insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $274 in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Addex Therapeutics Ltd. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021 All holders in Q1 2021

13F holders of ADXN: Q1 2021 compared with Q2 2021
Measure	Q1 2021	Q2 2021	Change
Holders	3	4	+1
Shares	280.1K	508.7K	+228.6K (+81.6%)
Value	$2.94M	$20.4M	+$17.4M (+592.4%)

New holders (2)

Institutions that held Addex Therapeutics Ltd. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to ADXN in Q2 2021
Institution	Shares	Value	% of portfolio
NEA Management Company, LLC	180,000	$17.2M	0.22%
New Leaf Venture Partners, L.L.C.	50,000	$478.0K	0.16%

Sold out (1)

Institutions that held Addex Therapeutics Ltd. at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of ADXN in Q2 2021
Institution	Shares, Q1 2021	Value, Q1 2021
Citadel Advisors LLC	11,604	$121.0K